Who is sponsoring VITAL?

VITAL is sponsored by Bactiguard AB.

What condition does VITAL study?

VITAL studies Ventilator-associated Pneumonia.

What drugs are being tested in VITAL?

Interventions: ETTEvac, BIP ETTEvac.

Last reviewed 2021-01-20 · How we verify

VITAL - VAP Prevention by BIP (Bactiguard Infection Protection) ETT Evac in Belgian ICUs

NCT04242706 PHASE4 COMPLETED

The study objective is to determine VAP (Ventilator Associated Pneumonia) baseline incidence in the ICU in patients receiving endotracheal tubes with evacuation lumen with and without Bactiguard coating. The study is randomized, prospective, controlled and blinded. All adult patients hospitalized in the ICUs from two tertiary hospitals (i.e.: Centre Hospitalier Universitaire Sart Tilman Liège , Centre Hospitalier Chrétien de Liège) and considered to be ventilated for more than 24 hours will be eligible to participate in the study.

Details

Lead sponsor	Bactiguard AB
Phase	PHASE4
Status	COMPLETED
Enrolment	323
Start date	Wed Oct 31 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Fri May 08 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Ventilator-associated Pneumonia

Interventions

ETTEvac
BIP ETTEvac

Countries

Belgium